SANA Earnings — Sana Biotechnology, Inc. Common Stock Post-ER Performance | BigEarnings
SANA — Sana Biotechnology, Inc. Common Stock
XNAS
Price$3.24
Market Cap$893.3M
P/E—
52W Range$2.10 – $6.55
Next Earnings2026-08-10
About Sana Biotechnology, Inc. Common Stock
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
